Akebia Therapeutics, Inc. (FRA:AX9)

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $58.77M USD in the quarter ending September 30, 2025, with 57.01% growth. This brings the company's revenue in the last twelve months to $225.07M, up 32.49% year-over-year. In the year 2024, Akebia Therapeutics had annual revenue of $160.18M, down -17.70%.

• Revenue (ttm): $225.07M
• Revenue Growth: +32.49%
• P/S Ratio: 1.80
• Revenue / Employee: $1.24M
• Employees: 181
• Market Cap: 344.68M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	160.18M	-34.44M	-17.70%
Dec 31, 2023	194.62M	-97.86M	-33.46%
Dec 31, 2022	292.48M	80.83M	38.19%
Dec 31, 2021	211.65M	-82.99M	-28.17%
Dec 31, 2020	294.64M	-40.36M	-12.05%
Dec 31, 2019	335.00M	127.26M	61.26%
Dec 31, 2018	207.74M	26.52M	14.63%
Dec 31, 2017	181.23M	179.69M	11,706.32%
Dec 31, 2016	1.54M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-